DOUGLAS J. SWIRSKY

Profile

First Name

: DOUGLAS

Middle Name

: J.

Last Name

: SWIRSKY

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
GENVEC INC
PAUL H. FISCHER, WAYNE T. HOCKMEYER, ZOLA P. HOROVITZ, WILLIAM N. KELLEY, KEVIN M. ROONEY, JOSHUA RUCH, MARC SCHNEEBAUM
DIRECTOR
FIBROCELL SCIENCE, INC.
SEAN D. BUCKLEY, DECLAN DALY, KEITH A. GOLDAN, PAUL HOPPER, JULIAN KIRK, JULIAN P. KIRK, GEORGE KORKOS, GEORGE J. KORKOS, ROBERT LANGER, ROBERT LANGOR, MICHAEL F. MARINO, JOHN MASLOWSKI, JOHN M. MASLOWSKI, MARC MAZUR, MARC B. MAZUR, KELVIN MOORE, KELVIN D. MOORE, DAVID PERNOCK, MARCUS SMITH, MARCUS E. SMITH, CHRISTINE ST.CLARE
DIRECTOR
CELLECTAR BIOSCIENCES, INC.
CHARLES T. BERNHARDT, PAUL BERNS, JAMES V. CARUSO, ASHER ALBAN CHANAN-KAHN, MICHAEL J. DOYLE, FREDERICK W DRISCOLL, FREDERICK W. DRISCOLL, DOV ELEFANT, SIMM FASS, JOHN FRIEND, JOHN E. FRIEND II, JOHN P. HAMILL, KIM HAWKINS, STEPHEN A. HILL, CHAD J. KOLEAN, DARRELL SHANE LEA, JARROD LONGCOR, STEFAN LOREN, STEFAN D. LOREN, THOMAS ROCKWELL MACKIE, JAMES S. MANUSO, DAVID B. MCWILLIAMS, JOHN E. NEIDERHUBER, JOHN NEIS, ELIAS NYBERG, HARRY S. PALMIN, CHRISTOPHER J. PAZOLES, SIMON PEDDER, JOANNE M. PROTANO, HOWARD M. SCHNEIDER, KRISTIN C. SCHUHWERK, ANDREI SHUSTOV, MICHAEL F. TWEEDLE, JAMEY P. WEICHERT
EXECUTIVE OFFICER, DIRECTOR
AAVANTIBIO, INC.
BARRY J. BYRNE, M.D., PH.D., MANUELA CORTI, PT, PH.D., BO CUMBO, ELLEN HUKKELHOVEN, PH.D., PHILIP R. JOHNSON, M.D., BENJAMIN LUND, JAKE SIMSON
DIRECTOR
NEUROBO PHARMACEUTICALS, INC.
AKASH BAKSHI, ANDREW BARTYNSKI, CHARLES BISGAIER, MARK A. GLICKMAN, LEE S. GOLDEN, JASON GROVES, JASON L. GROVES, STEVE GULLANS, STEPHEN HAAKENSON, P. KENT HAWRYLUK, RICHARD J. KANG, HYUNG HEON KIM, NA YEON KIM, KENNETH KOUSKY, ANDREW KOVEN, ANDREW I KOVEN, PEDRO LICHTINGER, DAVID LOWENSCHUSS, NADJA MANNOWETZ, JEFFREY MATHIESEN, MARGARET MCSHANE, JEONG GYUN OH, DANIELA ONICIU, SETH RENO, MICHAEL SALSBURY, ANDY SASSINE, NICOLA SHANNON, MINA SOOCH, D. GORDON STRICKLAND, JAMES P. TURSI, MARSHALL H. WOODWORTH, AMY ZAREMBA RABOURN
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-09-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-09-08 
2021-10-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-10-01 
2021-02-01
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-01-21 
2021-01-12
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-31 
2021-01-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2020-12-28 
2020-11-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-21 
2019-05-31
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2019-05-20 
2018-12-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-12-07 
2018-07-17
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-07-02 
2018-06-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-05-29 
2017-10-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2017-10-12 
2016-08-24
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-08-09 
2010-01-28
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2010-01-13